Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor

International Journal of Molecular Medicine

Volumn 29, Issue 4, 2012, Pages 581-586

  Cho, Il Rae ^a   Oh, Myungju ^a   Koh, Sang Seok ^b   Malilas, Waraporn ^a   Srisuttee, Ratakorn ^a   Jhun, Byung Hak ^a   Pellegrini, Sandra ^c   Fuchs, Serge Y ^d   Chung, Young Hwa ^a  

^a Pusan National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hepatitis B virus X; IFN receptor; IFN signaling; Tyk2

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; HEPATITIS B VIRUS X PROTEIN; PROTEIN INTERFERON ALPHA RECEPTOR 1; PROTEIN KINASE TYK2; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; DOWN REGULATION; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CELL LINE; DOWN-REGULATION; HEPATITIS B VIRUS; HUMANS; INTERFERON-ALPHA; RECEPTOR, INTERFERON ALPHA-BETA; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; TYK2 KINASE;

EID: 84858173426     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.879     Document Type: Article

References (38)

1. Payelle-Brogard B and Pellegrini S: Biochemical monitoring of the early endocytic traffic of the type Iinterferon receptor. J Interferon Cytokine Res 30: 89-98, 2010.
2. Yeh TC and Pellegrini S: The Janus kinase family of protein tyrosine kinases and their role in signaling. Cell Mol Life Sci 55: 1523-1534, 1999. (Pubitemid 29445818)
3. Stark GR, Kerr IM, Williams BR, Silverman RH and Schreiber RD: How cells respond to interferons. Annu Rev Biochem 67: 227-264, 1998. (Pubitemid 28411130)
4. Bonifacino JS and Traub LM: Signals for sorting of transmembraneproteins to endosomes and lysosomes. Annu Rev Biochem 72: 395-447, 2003. (Pubitemid 36930451)
5. Kumar KG, Barriere H, Carbone CJ, Liu J, Swaminathan G, Xu P, Li Y,Baker DP, Peng J, Lukacs GL and Fuchs SY: Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J Cell Biol 179: 935-950, 2007. (Pubitemid 350223490)
6. Liu J, Plotnikov A, Banerjee A, Suresh Kumar KG, Ragimbeau J, Marijanovic Z, Baker DP, Pellegrini S and Fuchs SY: Ligand-independent pathway that controls stability of interferon alpha receptor. Biochem Biophys Res Commun 367: 388-393, 2008.
7. Ragimbeau J, Dondi E, Alcover A, Eid P, Uze G and Pellegrini S: The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression. EMBO J 22: 537-547, 2003. (Pubitemid 36193598)
8. Kumar KG, Varghese B, Banerjee A, Baker DP, Constantinescu SN, Pellegrini S and Fuchs SY: Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif. J Biol Chem 283: 18566-18572, 2008.
9. Nguyen DH, Ludgate L and Hu J: Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol 216: 289-294, 2008. (Pubitemid 351898452)
10. Waris G, Huh KW and Siddiqui A: Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol 21: 7721-7730, 2001. (Pubitemid 32988782)
11. Kekule AS, Lauer U, Weiss L, Luber B and Hofschneider PH: Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361: 742-745, 1993. (Pubitemid 23070485)
12. Lee YH and Yun Y: HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem 273: 25510-25515, 1998.
13. Lee YI, Kang-Park S, Do SI and Lee YI: The hepatitis B virus-X protein activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J Biol Chem 276: 16969-16977, 2001.
14. Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M and Natoli G: Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway. J Virol 70: 641-646, 1996. (Pubitemid 126508839)
15. Kim H, Lee YH, Won J and Yun Y: Through induction of juxta-position and tyrosine kinase activity of Jak1, X-gene product of hepatitis B virus stimulates Ras and the transcriptional activation through AP-1, NF-kappaB, and SRE enhancers. Biochem Biophys Res Commun 286: 886-894, 2001. (Pubitemid 32924856)
16. Chen J and Siddiqui A: Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress. J Virol 81: 6757-6760, 2007. (Pubitemid 46878080)
17. Srisuttee R, Koh SS, Park EH, Cho IR, Min HJ, Jhun BH, Yu DY, Park S, Park do Y, Lee MO, et al: Upregulation of Foxo4 mediated by hepatitis B virus X protein confers resistance to oxidative stress-induced cell death. Int J Mol Med 28: 255-260, 2011.
18. Park EH, Koh SS, Srisuttee R, Cho IR, Min HJ, Jhun BH, Lee YS, Jang KL, Kim CH, Johnston RN and Chung YH: Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells. Cancer Gene Ther 16: 453-461, 2009.
19. Cho IR, Jeong S, Jhun BH, An WG, Lee B, Kwak YT, Lee SH, Jung JU and Chung YH: Activation of non-canonical NF-kappaB pathway mediated by STP-A11, an oncoprotein of Herpesvirus saimiri. Virology 359: 37-45, 2007. (Pubitemid 46215693)
20. Ide H, Nakagawa T, Terado Y, Kamiyama Y, Muto S and Horie S: Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells. Biochem Biophys Res Commun 369: 292-296, 2008. (Pubitemid 351400466)
21. Mulrooney-Cousins PM and Michalak TI: Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J Gastroenterol 13: 5682-5686, 2007. (Pubitemid 350120219)
22. Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell 140: 883-899, 2010.
23. Borrello MG, Degl'Innocenti D and Pierotti MA: Inflammation and cancer:the oncogene-driven connection. Cancer Lett 267: 262-270, 2008.
24. Li S, Labrecque S, Gauzzi MC, Cuddihy AR, WongAH, Pellegrini S, Matlashewski GJ and Koromilas AE: The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18: 5727-5737, 1999. (Pubitemid 29507426)
25. Lin RJ, Liao CL, Lin E and Lin YL: Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 78: 9285-9294, 2004. (Pubitemid 39096538)
26. Guo JT, Hayashi J and Seeger C: West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol 79: 1343-1350, 2005. (Pubitemid 40459081)
27. Garcin D, Marq JB, Strahle L, le Mercier P and Kolakofsky D: All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 295: 256-265, 2002. (Pubitemid 34921311)
28. Gotoh B, Komatsu T, Takeuchi K and Yokoo J: Paramyxovirus strategies for evading the interferon response. Rev Med Virol 12: 337-357, 2002. (Pubitemid 35334421)
29. Barnard P and McMillan NA: The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology 259: 305-313, 1999. (Pubitemid 29393381)
30. Look DC, Roswit WT, Frick AG, Gris-Alevy Y, Dickhaus DM, Walter MJ and Holtzman MJ: Direct suppression of Stat1 function during adenoviral infection. Immunity 9: 871-880, 1998. (Pubitemid 29024466)
31. Christen V, Duong F, Bernsmeier C, Sun D, Nassal M and Heim MH: Inhibition of alpha interferon signaling by hepatitis B virus. J Virol 81: 159-165, 2007. (Pubitemid 44975156)
32. Bisson SA, Page AL and Ganem D: A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction. J Virol 83: 5056-5066, 2009.
33. Wu C, Guan Q, Wang Y, Zhao ZJ and Zhou GW: SHP-1 suppresses cancer cell growth by promoting degradation of JAK kinases. J Cell Biochem 90: 1026-1037, 2003. (Pubitemid 37467118)
34. Cheng J, Zhang D, Zhou C and Marasco WA: Downregulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed humanperipheral blood CD4+ T-cells. Leuk Res 28: 71-82, 2004. (Pubitemid 37433796)
35. Wu C, Sun M, Liu L and Zhou GW: The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 306: 1-12, 2003. (Pubitemid 36351390)
36. Chung TW, Lee YC, Ko JH and Kim CH: Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells. Cancer Res 63: 3453-3458, 2003. (Pubitemid 36793019)
37. Abdelmohsen K, Pullmann R Jr, Lal A, Kim HH, Galban S, Yang X, Blethrow JD, Walker M, Shubert J, Gillespie DA, et al: Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25: 543-557, 2007. (Pubitemid 46274441)
38. Jung JK, Arora P, Pagano JS and Jang KL: Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res 67: 5771-5778, 2007. (Pubitemid 46985010)